The newly launched bone graft is available in putty and strip configurations, according to a news release. OsteoCove has a specialized granule surface topography for bone forming and is made of biphasic ceramic granule comprised of β-tricalcium phosphate and hydroxyapatitecombined with type-I bovine collagen.
“With the introduction of OsteoCove, we expect strong growth in this large market segment as we continue to deliver on our commitment to provide surgeons a comprehensive offering of biologic solutions to meet the needs of their patients,” Tyler Lipschultz, President of global biologics, said in the release.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
